Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fed Conditions
NCT01703468
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
59
Enrollment
INDUSTRY
Sponsor class
Conditions
Seizures
Interventions
DRUG:
Oxcarbazepine
Sponsor
Roxane Laboratories